PharmaShots | Incisive News in 3 Shots

Subscribe Now

Gamida Cell

Gamida Cell’s Omisirge (omidubicel-onlv) Receives the US FDA’s Approval for Hematologic Malignancies

Gamida Cell’s Omisirge (omidubicel-onlv) Receives the US FDA’s Approval for Hematologic Malignancies

April 18, 2023

Gamida Cell Reports First Patient Dosing in P-I/II Study of GDA-201 for the Treatment of Follicular and Diffuse Large B Cell Lymphoma

Gamida Cell Reports First Patient Dosing in P-I/II Study of GDA-201 for the Treatment of Follicular and Diffuse Large B Cell Lymph...

August 10, 2022

Gamida Cell Receives the US FDA’s IND Clearance and Removal of Clinical Hold of GDA-201 for the Treatment of Follicular and Diffuse Large B Cell Lymphoma

Gamida Cell Receives the US FDA’s IND Clearance and Removal of Clinical Hold of GDA-201 for the Treatment of Follicular and Diffus...

April 26, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us